Activists gather to discuss issues faced by women living with HIV and AIDS in Eastern Europe and Central Asia

On 6 and 7 June in Minsk, Belarus, the Public Health and Social Development Foundation, FOCUS-MEDIA, with organizational and logistical support from ITPCru, held an international conference for women affected by HIV across the Eastern Europe and Central Asia region. Participants included activists from the EVA Women’s Network, the Candle Foundation (Russia), the Community of […]

HIV treatment advocates from MENA region demand lower prices for key drugs

Today, the Middle East North Africa (MENA) region is considered to have one of fastest growing HIV epidemics in the world and the lowest rate of treatment coverage – with only 14% of people in need receiving antiretroviral therapy. ITPC MENA and ALCS-Maroc recently organized a World Community Advisory Board meeting, bringing together 17 activists […]

urn-uuid-52c308cf-1336-408e-8f57-c51309321498_700x400_base

Grassroot activists work for treatment access across Russia

Between June and August 2014, the Patients in Control initiative, a grassroots movement centered on treatment advocacy in Russia, received nearly 25 private appeals from patients regarding the unexpected replacement of their treatment regimens. These appeals came from ten regions across the nation, including Ivanovo, Tatarstan, Kaliningrad, Krasnoyarsk, Murmansk, Moscow, Nizhny Novgorod, Perm, Rostov-on-Don and […]

ITPC in the media

ITPC staff and activities were recently featured in several media outlets. Aidsmap highlighted ITPC’s July 2014 report, Global Policy, Local Disconnects, in a review of important guidelines and resources discussed at the International AIDS Conference (IAC). ITPC Executive Director Christine Stegling is also quoted. A new Drug Reporter video from the IAC features a snapshot […]

ITPC China works to eliminate d4T

The International Treatment Preparedness Coalition (ITPC) – China is working to support the immediate phase out of d4T, an anti-retroviral drug that has serious side effects. For several years, the World Health Organization (WHO) has raised concerns over d4T’s high levels of toxicity, and no longer recommends it as an optimal first line ARV. Although […]

Strong Participation of ITPC and Allies in the Brasilia Consultation on Access to Medicines in the Middle Income Countries

By 2020, most of people living with HIV will be living in the middle-income countries (MICs), where inequality in access is still high. HIV treatment coverage rates observed in regions like Eastern Europe and Central Asia (EECA) and Middle‐East and North Africa (MENA) and other MICs remain among the lowest in the world. Currently, middle […]

Anti TB Drug Stock- outs

Drug stock outs have dominated many discussions that look at barriers to treatment access for communicable infectious diseases. The main reason for concern when stock outs occur is mostly due to the propagation of drug resistance as a result of failing regimens. So when the custodian of a taxpaying citizen facing the dangers caused by […]